MedTrace Logo

Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

NCT00446563 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2011-05-11

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and efficacy of amlodipine plus valsartan in patients with hypertension and left ventricular hypertrophy

Conditions

  • Hypertension; Hypertrophy, Left Ventricular

Interventions

DRUG

Valsartan

160 mg film coated tablets taken orally once daily in the morning.

DRUG

Amlodipine

5 mg or 10 mg tablets taken orally once daily in the morning.

DRUG

Hydrochlorothiazide

12.5 mg or 25 mg tablets taken orally once daily in the morning.

DRUG

Losartan

100 mg tablets taken orally once daily in the morning.

Sponsors & Collaborators

Principal Investigators

  • Novartis · Novartis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00446563 on ClinicalTrials.gov